ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

FRANCISCO VAZQUEZ REILLO M.D.

At A Glance: This Prescriber in 2012

Neurology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,457Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 71

$1.08M Total Retail Price of All Prescriptions

Rank: 8 out of 71

923 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
1% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Puerto Rico
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 923 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

3% of this provider’s 923 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

4% of this provider’s 4,973 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

36% of this provider’s prescriptions were for brand-name drugs, compared to an average of 34%.

Prescription Price

$145 was the average price of a prescription from this provider, compared to $113 among peers.

Prescriptions per Patient

8 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
DONEPEZIL HCL 912 883 1 1
EXELON 553 544 2 6
GABAPENTIN 501 287 3 3
NAMENDA 448 437 4 2
LYRICA 234 131 5 12
TOPIRAMATE 232 189 6 29
GALANTAMINE HBR 224 218 7 5
DICLOFENAC POTASSIUM 173 53 8 25
PRAMIPEXOLE DIHYDROCHLORIDE 170 134 9 8
TIZANIDINE HCL 168 48 10 17
LAMOTRIGINE 162 56 11 21
TRIHEXYPHENIDYL HCL 152 120 R 12 51
OXCARBAZEPINE 126 97 13 38
TRAMADOL HCL 118 58 14 30
DILANTIN 116 23 15 28
LEVETIRACETAM 101 49 16 9
TRAMADOL HCL-ACETAMINOPHEN 95 0 17 11
CLOPIDOGREL 83 54 18 19
AMANTADINE 75 60 19 41
ORPHENADRINE CITRATE 73 0 R 20 39
RANITIDINE HCL 67 38 21 24
LIPOFLAVOVIT 66 57 10 22 140
CARBIDOPA-LEVODOPA 63 55 23 4
QUETIAPINE FUMARATE 59 59 24 14
ZOLPIDEM TARTRATE 57 40 25 15
INDOMETHACIN 57 13 R 25 94
PRIMIDONE 56 40 27 23
CYMBALTA 55 45 28 16
AMITRIPTYLINE HCL 55 43 R 28 18
VITAMIN B-12 54 40 30 67
PROPRANOLOL HCL 52 48 31 32
ETODOLAC 51 0 32 33
PHENYTOIN SODIUM EXTENDED 51 25 32 58
STALEVO 75 50 44 10 34 155
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 28, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.